Assessment of drug-eluting stents and bioresorbable stents by grayscale IVUS and IVUS-based imaging modalities

International Journal of Cardiovascular Imaging

Volumn 27, Issue 2, 2011, Pages 239-248

  Brugaletta, Salvatore ^a   Costa Jr , Jose Ribamar ^b   Garcia Garcia, Hector M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

Intravascular ultrasound; Stent; Tissue characterization

Indexed keywords

BIODEGRADABLE IMPLANT; COMPUTER ASSISTED DIAGNOSIS; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HUMAN; INSTRUMENTATION; PREDICTIVE VALUE; PROSTHESIS; RESTENOSIS; REVIEW; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; THROMBOSIS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79961175304     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-010-9788-8     Document Type: Review

References (52)

1. Das P, Meredith I (2007) Role of intravascular ultrasound in unprotected left main percutaneous coronary intervention. Expert Rev Cardiovasc Ther 5:81-89 (Pubitemid 46157743)
2. Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al (2006) ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113:156-75 (Pubitemid 43958502)
3. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG (2002) Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106:2200-2206 (Pubitemid 35222213)
4. Nair A, Margolis MP, Kuban BD, Vince DG (2007) Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. EuroIntervention 3:113-120
5. Ramcharitar S, Garcia-Garcia HM, Nakazawa G et al (2007) Ultrasonic and pathological evidence of a neointimal plaque rupture in patients with bare metal stents. EuroIntervention 3:290-291
6. Kubo T, Maehara A, Mintz GS et al (2010) Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound. Am Heart J 159:271-277
7. Garcia-Garcia HM, Gonzalo N, Pawar R et al (2009) Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial. EuroIntervention 4:443-448
8. Sarno G, Onuma Y, Garcia HM et al (2010) IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus-eluting device during the bioabsorption process. Catheter Cardiovasc Interv 75:914-918
9. Mintz GS (2007) Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound. Am J Cardiol 100:26M-35M
10. Moses JW, Dangas G, Mehran R, Mintz GS (2008) Drug-eluting stents in the real world: how intravascular ultrasound can improve clinical outcome. Am J Cardiol 102:24J-28J
11. Roy P, Steinberg DH, Sushinsky SJ et al (2008) The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 29:1851-1857
12. Costa MA, Angiolillo DJ, Tannenbaum M et al (2008) Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial). Am J Cardiol 101:1704-1711
13. de Jaegere P, Mudra H, Figulla H et al (1998) Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the multicenter ultrasound stenting in coronaries study (MUSIC Study). Eur Heart J 19:1214-1223 (Pubitemid 28362605)
14. Fujii K, Carlier SG, Mintz GS et al (2005) Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45:995-998 (Pubitemid 40432428)
15. Okabe T, Mintz GS, Buch AN et al (2007) Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol 100:615-620 (Pubitemid 47223136)
16. Sonoda S, Morino Y, Ako J et al (2004) Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol 43:1959-1963 (Pubitemid 38686788)
17. Hong MK, Mintz GS, Lee CW et al (2006) Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 27:1305-1310 (Pubitemid 43998103)
18. Sakurai R, Ako J, Morino Y et al (2005) Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). Am J Cardiol 96:1251-1253 (Pubitemid 41505403)
19. Wentzel JJ, Gijsen FJ, Stergiopulos N, Serruys PW, Slager CJ, Krams R (2003) Shear stress, vascular remodeling and neointimal formation. J Biomech 36:681-688 (Pubitemid 36407620)
20. Serruys PW, Degertekin M, Tanabe K et al (2004) Vascular responses at proximal and distal edges of paclitaxeleluting stents: serial intravascular ultrasound analysis from the TAXUS II trial. Circulation 109:627-633 (Pubitemid 38198870)
21. Weissman NJ, Koglin J, Cox DA et al (2005) Polymerbased paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 45:1201-1205 (Pubitemid 40523137)
22. Sakurai R, Hongo Y, Yamasaki M et al (2007) Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Am J Cardiol 100:818-823
23. Aoki J, Colombo A, Dudek D et al (2005) Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation 112:3876-3883 (Pubitemid 43739485)
24. Tanabe K, Serruys PW, Degertekin M et al (2005) Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation 111:900-905 (Pubitemid 40279892)
25. Ako J, Morino Y, Honda Y et al (2005) Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 46:1002-1005 (Pubitemid 41316506)
26. Kimura M, Mintz GS, Carlier S et al (2006) Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. Am J Cardiol 98:436-442 (Pubitemid 44162867)
27. Hong MK, Mintz GS, Lee CW et al (2006) Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113:414-419 (Pubitemid 43803203)
28. Serruys PW, Ruygrok P, Neuzner J et al (2006) A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial. EuroIntervention 2:286-294
29. Escolar E, Mintz GS, Popma J et al (2007) Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI). Am J Cardiol 100:621-626 (Pubitemid 47241135)
30. Cook S, Wenaweser P, Togni M et al (2007) Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115:2426-2434 (Pubitemid 46717965)
31. de Ribamar Costa J, Mintz GS Jr, Carlier SG Jr et al (2007) Intravascular ultrasound assessment of drug-eluting stent expansion. Am Heart J 153:297-303 (Pubitemid 46096874)
32. Shaikh F, Maddikunta R, Djelmami-Hani M, Solis J, Allaqaband S, Bajwa T (2008) Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis? Catheter Cardiovasc Interv 71:614-618 (Pubitemid 351550399)
33. Yamada KP, Koizumi T, Yamaguchi H et al (2008) Serial angiographic and intravascular ultrasound analysis of late stent strut fracture of sirolimus-eluting stents in native coronary arteries. Int J Cardiol 130:255-259
34. Doi H, Maehara A, Mintz GS et al (2009) Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. Am J Cardiol 103:818-823
35. Farb A, Kolodgie FD, Hwang JY et al (2004) Extracellular matrix changes in stented human coronary arteries. Circulation 110:940-947 (Pubitemid 39128619)
36. Finn AV, Nakazawa G, Joner M et al (2007) Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27:1500-1510 (Pubitemid 46986103)
37. Nasu K, Tsuchikane E, Katoh O et al (2006) Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 47:2405-2412 (Pubitemid 43866370)
38. Farb A, Burke AP, Kolodgie FD, Virmani R (2003) Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108:1701-1706 (Pubitemid 37243657)
39. MP NairA, Kuban BD, Vince DG (2007) Automated coronary plaque characterization with intravascular ultrasound backscatter: ex vivo validation. Eurointervention 3:113-130
40. Garcia-Garcia HM, Goedhart D, Serruys PW (2007) Relation of plaque size to necrotic core in the three major coronary arteries in patients with acute coronary syndrome as determined by intravascular ultrasonic imaging radiofrequency. Am J Cardiol 99:790-792 (Pubitemid 46365598)
41. Ramcharitar S, Gonzalo N, van Geuns RJ et al (2009) First case of stenting of a vulnerable plaque in the SECRITT I trial-the dawn of a new era? Nat Rev Cardiol 6:374-378
42. Kim SW, Mintz GS, Hong YJ et al (2008) The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents. Am J Cardiol 102:1182-1186
43. Serruys PW, Ormiston JA, Onuma Y et al (2009) A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373:897-910
44. Ormiston JA, Serruys PW, Regar E et al (2008) A bioabsorbable everolimus-eluting coronary stent system for patients with single de novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 371:899-907 (Pubitemid 351384734)
45. Aoki J, Abizaid AC, Serruys PW et al (2005) Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol 46:1670-1676 (Pubitemid 41531621)
46. Garcia-Garcia HM, Gonzalo N, Tanimoto S, Meliga E, de Jaegere P, Serruys PW (2008) Characterization of edge effects with paclitaxel-eluting stents using serial intravascular ultrasound radiofrequency data analysis: the BETAX (BEside TAXus) Study. Rev Esp Cardiol 61:1013-1019
47. Sathyanarayana S, Carlier S, Li W, Thomas L (2009) Characterisation of atherosclerotic plaque by spectral similarity of radiofrequency intravascular ultrasound signals. EuroIntervention 5:133-139
48. Shin ES, Garcia Garcia HM, Lighthart J, et al (2010) In Vivo Findings of Tissue Characteristics using iMap™ IVUS and Virtual Histology™ IVUS EuroInterv In press 2010
49. de Korte CL, Sierevogel MJ, Mastik F et al (2002) Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo: a Yucatan pig study. Circulation 105:1627-1630 (Pubitemid 34298602)
50. Van Mieghem CA, McFadden EP, de Feyter PJ et al (2006) Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities: the Integrated Biomarker and Imaging Study (IBIS). J Am Coll Cardiol 47:1134-1142
51. Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI (2009) Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC Cardiovasc Interv 2:1035-1046
52. Bouma BE, Tearney GJ, Yabushita H et al (2003) Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart 89:317-320 (Pubitemid 36241548)